Sofinnova Investments, Inc.

Sofinnova Investments, Inc.

Sofinnova Investments, Inc.

Overview
Date Founded

1988

Headquarters

3000 Sand Hill Road,Building 4,Suite 250,Menlo Park, CA 94025-7113

Type of Company

Private

Employees (Worldwide)

27

Industries

Private Equity & Venture Capital
Hospitals & Patient Services
Biotechnology
Investment Services & Portfolio Management

Company Description

Sofinnova Investment Inc. invests in companies located in the US and Europe. The firm targets companies operating in the fields of health and technology services. It provides financing for early and later stage capital requirements with investment size ranges from $15 to $35 million. It invests in both private & public companies.

Contact Data
Trying to get in touch with decision makers at Sofinnova Investments, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founding Partner

Managing Partner

Chief Compliance Officer & Chief Operating Officer

Executive Partner, Private Equity

Executive Partner, Private Equity

Executive Partner, Private Equity

Executive Partner, Private Equity

Partner & Chief Legal Officer

General Partner

General Partner

Board of Directors

Managing Partner at Sofinnova Investments, Inc.

Partner & Chief Financial Officer at Sofinnova Investments, Inc.

General Partner at Sofinnova Investments, Inc.

Paths to Sofinnova Investments, Inc.
Potential Connections via
Relationship Science
You
Sofinnova Investments, Inc.
Recent Transactions
Details Hidden

Thomson-CSF purchases Guavus, Inc. from Intel Capital Corp., Patricia Industries, Inc., Sofinnova Investments, Inc., Questmark Management Co. LLC, Artiman Management LLC

Details Hidden

Suzhou Chunxing Precision Mechanical Co., Ltd. purchases CALIENT Technologies, Inc. from Sofinnova Investments, Inc., TeleSoft Partners, Cayuga Management Group LLC, SDL Ventures LLC, Intuitive Venture Partners LLC

Details Hidden

ImmunogenX LLC, Immunogenics LLC purchase Alvine Pharmaceuticals, Inc. from Sofinnova Investments, Inc., Flagship Pioneering, InterWest Partners, LLC, Prospect Venture Partners, Panorama Capital LLC, Abbott Ventures, Inc., Proterra Investment Partners LP, AbbVie Biotech Ventures, Inc.

Transaction Advisors
Escrow Agent

Advised onTargacept, Inc. purchases Catalyst Biosciences, Inc. (Inactive) from Sofinnova Investments, Inc., Burrill LLC, Johnson & Johnson Innovation JJDC, Inc., HealthCare Ventures LLC, Rosetta Capital Ltd., Morgenthaler Management Corp.

Escrow Agent

Advised onInphi Corp. purchases Cortina Systems, Inc. from INVESCO Private Capital, Inc., Alloy Ventures, Inc., Canaan Management, Inc., Institutional Venture Partners, Sofinnova Investments, Inc., Redpoint Ventures, Intel Capital Corp., Kodiak Venture Partners, Doll Capital Management, Inc., Icon Ventures LLC, EDV Management Co., Hotung Capital Management, Inc., Morgenthaler Management Corp., Bridgescale LLC, Vedanta Capital LLC

Advisors & Consultants
Custodian

Goldman, Sachs & Co. (GS&Co.), a limited partnership registered as a U.S. broker-dealer and futures commission merchant, together with its consolidated subsidiaries (collectively, the firm), is an indirectly wholly owned subsidiary of The Goldman Sachs Group, Inc. (Group Inc.), a Delaware corporation. The firm is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals.

Auditor

BDO USA, LLP is the United States Member Firm of BDO International, a global professional services network. BDO USA, LLP was founded as Seidman and Seidman in New York City in 1910 by three immigrant brothers: Maximillian L. Seidman, Francis E. Seidman, and Jacob S. Seidman.

Custodian

J.P. Morgan Securities offers a broad array of investment products and the world’s leading investment managers. These expansive resources—the best people and products in the industry coupled with a Financial Advisor who is directly involved in the investment process—are the true benefits of working with it.

Legal Advisor

Founding Partner at Wilson Sonsini Goodrich & Rosati PC

Non-Profit Donations & Grants
$1,000 - $2,499
2006
Investments
Details Hidden

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.

Details Hidden

Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA.

Details Hidden

Vera Therapeutics, Inc. is an American company located in South San Francisco, CA. The firm operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases. It was founded by Marshall Fordyce, who is the current CEO of the firm.The company says this about itself: Vera Therapeutics is a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases. Vera's mission is to develop and commercialize transformative new therapies that improve patients' lives. Vera's lead program is atacicept, a fusion protein that is a dual inhibitor of B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which is in development for IgA nephropathy (IgAN), also known as Berger's disease. Longer-term, the Company is building a pipeline of clinical-stage molecules with the potential to substantially improve lives.

Investors
Details Hidden

Partner & Chief Financial Officer at Sofinnova Investments, Inc.

Details Hidden

General Partner at Sofinnova Investments, Inc.

Details Hidden

Managing Partner at Sofinnova Investments, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sofinnova Investments, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sofinnova Investments, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Sofinnova Investments, Inc..